文献速递妇科

在高容量中心接受初次肿瘤细胞减灭术的晚期卵巢癌女性中探讨收入和种族对生存的影响

Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center.
PubMed 文献 · Gynecol Oncol · 2018-01-01

该研究纳入2001年1月至2013年12月在本机构接受初次肿瘤细胞减灭术的963例IIIB-IV期高级别卵巢癌患者,以邮政编码对应的普查收入作为社会经济地位替代指标,分析种族/民族和收入与手术结局及总生存的关系。调整显著预后因素后,收入组间手术结局无显著差异(p=0.7281),总生存中位55.1个月,收入组(p=0.628)和种族/民族组(p=0.615)间总生存均无显著差异;与NHW相比,亚洲患者残留>1cm的可能性更高(AOR 2.32,95%CI 1.1-4.9,p=0.03)。

要点

  • 高容量中心晚期卵巢癌患者中未观察到手术结局和生存的显著社会人口学差异。
  • 与NHW相比,亚洲患者残留>1cm的可能性更高(AOR 2.32,95%CI 1.1-4.9,p=0.03)。
  • 收入组间手术结局无显著差异(p=0.7281),中位OS为55.1个月(95%CI 51.8-58.5)。

核心结论

  • 在高容量中心接受治疗的晚期卵巢癌女性中,未观察到手术结局和生存结局存在统计学显著的社会人口学差异。
  • 需要加大努力将诊疗集中到高容量中心并增加在高容量中心治疗患者的多样性。

研究设计与样本

  • 回顾性识别2001年1月至2013年12月在本机构接受初次肿瘤细胞减灭术的所有IIIB-IV期高级别卵巢癌患者,共963例。
  • 患者自我报告的种族/民族分为非西班牙裔白人(NHW)、非西班牙裔黑人(NHB)、亚洲人(A)或西班牙裔(H)。
  • 使用邮政编码对应的普查报告收入水平作为社会经济地位的替代指标估计整个队列的收入水平。
  • 主要结局指标为初次肿瘤细胞减灭术结局和中位总生存期,采用Cox比例风险模型检验不同种族/民族和收入类别的总生存差异,并控制选定临床因素。

主要发现

  • 共识别963例患者进行分析:855例NHW、43例A、34例H、28例NHB和3例未知。
  • 与NHW相比,NHB和H的初次肿瘤细胞减灭术结局无显著差异。
  • 与NHW相比,亚洲患者残留>1cm的可能性更高(AOR 2.32,95%CI 1.1-4.9,p=0.03)。
  • 整个队列的中位收入为85,814美元(范围10,926-231,667美元)。
  • 调整显著预后因素后,收入组间初次肿瘤细胞减灭术结局无显著差异(p=0.7281);中位总生存期为55.1个月(95%CI 51.8-58.5),收入组(p=0.628)和种族/民族组(p=0.615)间总生存均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate patients with advanced ovarian cancer (OC) undergoing primary debulking surgery (PDS) at a high-volume center (HVC), to determine whether socio-demographic disparities in PDS outcome and overall survival (OS) were present. METHODS: All patients with stages IIIB-IV high-grade OC undergoing PDS at our institution from 1/2001-12/2013 were identified. Patients self-identified race/ethnicity as non-Hispanic White (NHW), non-Hispanic Black (NHB), Asian (A), or Hispanic (H). Income level for the entire cohort was estimated using the census-reported income level for each patient's zip code as a proxy for SES. Main outcome measures were PDS outcome and median OS. Cox proportional hazards model was used to examine differences in OS by racial/ethnic and income category, controlling for selected clinical factors. RESULTS: 963 patients were identified for analysis: 855 NHW; 43 A, 34H, 28 NHB, and 3 unknown. PDS outcome was not significantly different among NHB and H as compared to NHW. Compared to NHW, Asians were more likely to have >1cm residual (AOR 2.32, 95%CI 1.1-4.9, p=0.03). Median income for the entire cohort was $85,814 (range $10,926-$231,667). After adjusting for significant prognostic factors, there were no significant differences in PDS outcome between income groups (p=0.7281). Median OS was 55.1mos (95%CI 51.8-58.5) with no significant differences in OS between the income (p=0.628) or racial/ethnic (p=0.615) groups. CONCLUSION: Statistically significant socio-demographic disparities in PDS and survival outcomes were not observed among women with advanced OC treated at this HVC. Increased efforts are needed to centralize care to and increase the diversity of pts treated at HVCs.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Cowan RA, Tseng J, Ali N, et al. Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center. Gynecol Oncol. 2018. PMID: 29605049. doi:10.1016/j.ygyno.2017.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。